Cardiovascular System Drugs
Pharmacology
Institute of Health Sciences
Third Cycle (Doctorate Degree)
| Course Unit Title | Course Unit Code | Type of Course Unit | Level of Course Unit | Year of Study | Semester | ECTS Credits |
|---|---|---|---|---|---|---|
| Cardiovascular System Drugs | FRM612 | Compulsory | Doctorate degree | 2 | Fall | 6 |
Name of Lecturer(s)
Prof. Dr. Nejat GACAR
Prof. Dr. Feride İpek KOMSUOĞLU ÇELİKYURT
Learning Outcomes of the Course Unit
2) Explain mechanisms of blood pressure regulation and effective drugs and mechanisms of action here, the basic pharmacokinetic and pharmacodynamic properties, application areas of ischemic heart disease drugs, mechanism of action, classification, describes the basic pharmacokinetic and pharmacodynamic properties.
3) Explain mechanisms of action of drugs used in heart failure, basic pharmacokinetic and pharmacodynamic properties, the formation mechanism of arrhythmia
4) Explain the properties of antiarrhythmic drug action areas, the basic pharmacokinetic and pharmacodynamic
5) Explain drugs affecting the composition and volume of body fluids, thrombus and embolus formation mechanisms and effective drugs and mechanisms of action around here
6) Explain exogenous and endogenous lipid metabolism pathways and the mechanisms of effective drugs around here.
Program Competencies-Learning Outcomes Relation
| Program Competencies | |||||||||||||
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | ||
| Learning Outcomes | |||||||||||||
| 2 | No relation | No relation | No relation | No relation | No relation | No relation | No relation | No relation | No relation | No relation | No relation | No relation | |
| 3 | No relation | No relation | No relation | No relation | No relation | No relation | No relation | No relation | No relation | No relation | No relation | No relation | |
| 4 | No relation | No relation | No relation | No relation | No relation | No relation | No relation | No relation | No relation | No relation | No relation | No relation | |
| 5 | No relation | No relation | No relation | No relation | No relation | No relation | No relation | No relation | No relation | No relation | No relation | No relation | |
| 6 | No relation | No relation | No relation | No relation | No relation | No relation | No relation | No relation | No relation | No relation | No relation | No relation | |
Mode of Delivery
Face to Face
Prerequisites and Co-Requisites
None
Recommended Optional Programme Components
Drugs affecting the water, salt and acid and base balance
Course Contents
Antihypertensive drugs, Peripheral vasodilators, Antianginal drugs, Antiarrhythmic drugs, Cardiac glycosides and the other drugs used in heart failure, ?-adrenergic receptor blockers in heart failure, Hypolipidemic Drugs, Antithrombotic drugs:Anticoagulan drugs,Antitrombositic drugs and thrombolytic drugs, Hemostatical drugs and hemostatic blood products used for the repletion, The solutions that widen the plasma volume,blood and plasma products.
Weekly Schedule
1) Hypertension and regulation of the blood pressure2) Hypertension and regulation of the blood pressure
3) Basic pharmacology of antihypertensive agents
4) Inhibitors of Angiotensin
5) Clinical pharmacology of antihypertensive agents
6) Vasodilators and treatment of angina pectoris
7) Vasodilators
8) Drıg action in Angina
9) Drugs used in heart Failure
10) Drugs used in heart failure
11) Agents used in cardiac arrhytmias
12) Antiarrhythmics
13) Anticoagulants
14) Anticoagulants
15) General discussion
16) General discussion
Recommended or Required Reading
1- Katzung Pharmacology
Planned Learning Activities and Teaching Methods
1) Lecture
2) Question-Answer
Assessment Methods and Criteria
Contribution of Midterm Examination to Course Grade |
40% |
|---|---|
Contribution of Final Examination to Course Grade |
60% |
Total |
100% |
Language of Instruction
Turkish
Work Placement(s)
Not Required